Literature DB >> 21725884

Interventional value of total flavonoids from Rhizoma Drynariae on Cathepsin K, a potential target of osteoporosis.

Xiao-Lin Shi1, Kang Liu, Lian-Guo Wu.   

Abstract

Osteoporosis, the sixth most common disease in the world, is bringing increasingly serious harm to people's health. Cathepsin K, which plays an important role in bone resorption, is a potential target in the treatment of osteoporosis. Total flavonoids, the active ingredients in Rhizoma Drynariae, have shown obvious, therapeutic effect on osteoporosis. In previous studies, it was presumed that the mechanism for the therapeutic effect was through inhibiting the expression of Cathepsin K. However, there are still no detailed reports on some key issues such as the specific inhibitory results of total flavonoids on Cathepsin K and the pathway of inhibition and so on. Based on previous studies on total flavonoids from Rhizoma Drynariae, the pathway for the effect of, total flavonoids inhibiting Cathepsin K and their interventional value on Cathepsin K were analyzed in this paper, so as to explore the interventional feasibility and value of total flavonoids in Rhizoma Drynariae on Cathepsin K.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725884     DOI: 10.1007/s11655-010-0792-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  12 in total

1.  Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation.

Authors:  Thomas M Rünger; Maria Josefina Quintanilla-Dieck; Jag Bhawan
Journal:  J Invest Dermatol       Date:  2006-08-31       Impact factor: 8.551

2.  [Study the effects of flavonoids of Rhizoma Drynariae on gene level of rats without ovaries by technology of cDNA array].

Authors:  Yan-Ming Xie; Lin-Lin Qin; Jin-Biao Chen; Tian-Hong Cui; Wen-Jun Zhang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2005-07

3.  Optimized transfection of diced siRNA into mature primary human osteoclasts: inhibition of cathepsin K mediated bone resorption by siRNA.

Authors:  Christina I Selinger; Christopher J Day; Nigel A Morrison
Journal:  J Cell Biochem       Date:  2005-12-01       Impact factor: 4.429

4.  Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.

Authors:  Christian Meier; Udo Meinhardt; Jerry R Greenfield; James De Winter; Tuan V Nguyen; Colin R Dunstan; Markus J Seibel
Journal:  Clin Lab       Date:  2006       Impact factor: 1.138

5.  Human osteoblasts produce cathepsin K.

Authors:  Jami Mandelin; Mika Hukkanen; Tian-Fang Li; Matti Korhonen; Mikko Liljeström; Tarvo Sillat; Roeland Hanemaaijer; Jari Salo; Seppo Santavirta; Yrjö T Konttinen
Journal:  Bone       Date:  2005-12-05       Impact factor: 4.398

6.  Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.

Authors:  G B Stroup; M W Lark; D F Veber; A Bhattacharyya; S Blake; L C Dare; K F Erhard; S J Hoffman; I E James; R W Marquis; Y Ru; J A Vasko-Moser; B R Smith; T Tomaszek; M Gowen
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

7.  [Effect of osteopractic total flavone on bone mineral density and bone histomorphometry in ovariectomized rats].

Authors:  Yan-ming Xie; Da-hong Ju; Jin-ning Zhao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2004-04

8.  Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts.

Authors:  Ji-Cheon Jeong; Sung-Koo Kang; Cheol-Ho Youn; Chang-Whan Jeong; Hyung-Min Kim; Young-Choon Lee; Young-Chae Chang; Cheorl-Ho Kim
Journal:  Int Immunopharmacol       Date:  2003-11       Impact factor: 4.932

9.  Osteoprotegerin differentially regulates protease expression in osteoclast cultures.

Authors:  Y Wittrant; S Couillaud; S Theoleyre; C Dunstan; D Heymann; F Rédini
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

10.  Cathepsin K mRNA and protein expression in prostate cancer progression.

Authors:  K D Brubaker; R L Vessella; L D True; R Thomas; E Corey
Journal:  J Bone Miner Res       Date:  2003-02       Impact factor: 6.741

View more
  6 in total

Review 1.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

2.  An insight into the potentially old-wonder molecule-quercetin: the perspectives in foresee.

Authors:  Nidhi Rani; Lakshmi Palanisamy Thanga Velan; Saravanan Vijaykumar; Annamalai Arunachalam
Journal:  Chin J Integr Med       Date:  2015-09-09       Impact factor: 1.978

3.  Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology.

Authors:  Guihong Liang; Jinlong Zhao; Yaoxing Dou; Yuan Yang; Di Zhao; Zhanpeng Zhou; Rui Zhang; Weiyi Yang; Lingfeng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 6.055

4.  Antiosteoporosis effect of radix scutellariae extract on density and microstructure of long bones in tail-suspended sprague-dawley rats.

Authors:  Chen-Rui Li; Guang-Wei Zhang; Yin-Bo Niu; Ya-Lei Pan; Yuan-Kun Zhai; Qi-Bing Mei
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-09       Impact factor: 2.629

5.  Dual effects of baicalin on osteoclast differentiation and bone resorption.

Authors:  Xuanyuan Lu; Wei He; Wanlei Yang; Jianlei Li; Weiqi Han; Qian Liu; Tan Zhang; Jiawei Jiang; An Qin; Yu Qian
Journal:  J Cell Mol Med       Date:  2018-07-16       Impact factor: 5.310

6.  The Antiosteoporosis Effects of Zhuanggu Guanjie Pill In Vitro and In Vivo.

Authors:  Li-Juan Chai; Yue Zhang; Pan-Yang Zhang; Ya-Nan Bi; Xiao-Mei Yuan; Yu-Hong Li; Yan-Yan Wang; Lei Song; Li-Kang Sun; Kun Zhou
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.